BBLG
Bone Biologics
BBLG
BBLG
4 hedge funds and large institutions have $1.83K invested in Bone Biologics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CS
Clear Street
New York
|
+$556 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$455 |
Top Sellers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$19.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$419 |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $806 | -$419 | -104 | -34% |
|
|
CS
2
Clear Street
New York
| $556 | +$556 | +138 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $455 | +$455 | +113 | New |
|
4
Bank of America
Charlotte,
North Carolina
| $16 | – | – | – |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| – | -$19.4K | -4,034 | Closed |
|
|
SS
6
SBI Securities
Tokyo,
Japan
| – | -$1 | – | – |
|